Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Profit and Loss
Concord Drugs Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs & Formln  Chairman  : S Nagi Reddy
    Home        : Indian Private  Book Value: 34.11
    BSE Code  : 538965  Market Cap: 41.23
    NSE Code  :   P / E              : 137.43 

Change Company :
(Rs in Cr.)
Profit and Loss
ParticularsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Sales Turnover & Other Income 43.2751.3259.0655.2251.46
Excise Duty0.000.000.000.000.00
Total Income43.6750.8061.3753.5350.94
Raw Materials 33.7140.3644.4141.2842.06
Stock Adjustments 0.40-0.522.31-1.69-0.52
Other Manufacturing Expenses 0.390.440.430.600.40
Power & Fuel Cost0.000.000.000.000.77
Employee Cost 3.873.554.143.473.27
Selling and Administration Expenses 1.812.051.521.030.95
Miscellaneous Expenses 0.210.065.190.070.04
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Interest, Depreciation & Tax3.694.345.687.083.46
Interest & Financial Charges 1.591.621.681.421.54
Profit before Depreciation & Tax2.102.724.005.661.92
Depreciation1.541.601.761.371.46
Profit Before Tax0.561.122.244.290.46
Tax0.140.230.651.010.13
Profit After Tax0.420.891.593.280.33
Adjustment below Net Profit 0.000.000.010.000.00
P & L Balance brought forward14.4013.5111.918.638.30
Appropriations 0.000.000.000.000.00
P & L Bal. carried down14.8214.4013.5111.918.63
Equity Dividend0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)0.000.000.000.000.00
Earning Per Share (Rs.)0.420.961.823.750.38
Book Value33.8233.4332.4430.6126.86
Extraordinary Items 0.000.000.002.880.00
Top
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter   |   Investor Complaints   |   Smart ODR   |   Scores   |   Attention Investors   |

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by Capital Market Charts are powered by TradingView